Zobrazeno 1 - 4
of 4
pro vyhledávání: '"R. K. Raupov"'
Autor:
L. S. Sorokina, I. S. Avrusin, R. K. Raupov, N. T. Garipova, M. M. Gharabaghtsyan, S. V. Khrypov, M. A. Kaneva, E. A. Isupova, E. V. Gaidar, I. A. Chikova, M. F. Dubko, V. V. Masalova, T. S. Likhacheva, L. S. Snegireva, O. V. Kalashnikova, M. M. Kostik
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 1, Pp 102-111 (2022)
Systemic corticosteroids are continued to be administered in juvenile idiopathic arthritis (JIA) patients, especially in systemic JIA (sJIA), despite the ability of biologic therapy. One of the complications of long-term CS treatment is delayed hip a
Externí odkaz:
https://doaj.org/article/46434a680c7e46e1b670db62844d2c60
Autor:
E. M. Kalashnikova, R. K. Raupov, N. A. Lyubimova, E. M. Kuchinskaya, V. V. Masalova, E. A. Isupova, E. V. Gaidar, M. F. Dubko, L. S. Snegireva, L. S. Sorokina, T. L. Kornishina, M. A. Kaneva, I. A. Chikova, T. S. Likhacheva, O. L. Kolobova, O. V. Kalashnikova, V. G. Chasnyk, M. M. Kostik
Publikováno v:
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 68:74-84
Systemic lupus erythematosus is an immunopathological disease which is characterized by a poor prognosis. Biologics applied in the disease treatment allow reducing the corticosteroid toxicity and controlling the disease.Purpose. To evaluate the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::843dd991e9eb07d415bc1a8d60906560
https://doi.org/10.21508/1027-4065-2023-68-1-74-84
https://doi.org/10.21508/1027-4065-2023-68-1-74-84
Publikováno v:
Russian Clinical Laboratory Diagnostics. 66:279-284
Type 1 interferons (IFN1) are both key molecules of antiviral defense and potent inflammatory mediators. In 2003, increased expression of a variety of interferon 1-regulated genes was observed in a blood cells of patients with systemic lupus erythema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e772937221852f3d9add58bd64c0dbf
https://doi.org/10.51620/0869-2084-2021-66-5-279-284
https://doi.org/10.51620/0869-2084-2021-66-5-279-284
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 66(5)
Type 1 interferons (IFN1) are both key molecules of antiviral defense and potent inflammatory mediators. In 2003, increased expression of a variety of interferon 1-regulated genes was observed in a blood cells of patients with systemic lupus erythema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::09d0867855e232212c3f367e8e3e2473
https://pubmed.ncbi.nlm.nih.gov/34047513
https://pubmed.ncbi.nlm.nih.gov/34047513